UNICA IRIS Institutional Research Information System

DE LOGU, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 170.124
NA - Nord America 8.842
AS - Asia 3.781
SA - Sud America 614
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 6
Totale 183.444
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 166.872
US - Stati Uniti d'America 8.686
CN - Cina 1.653
SG - Singapore 1.597
UA - Ucraina 1.049
DE - Germania 586
SE - Svezia 580
BR - Brasile 476
FI - Finlandia 406
GB - Regno Unito 285
VN - Vietnam 146
FR - Francia 119
KR - Corea 113
CA - Canada 82
IN - India 73
MX - Messico 61
RU - Federazione Russa 42
AR - Argentina 38
BD - Bangladesh 36
MA - Marocco 35
NL - Olanda 35
EC - Ecuador 34
IQ - Iraq 24
ES - Italia 22
HK - Hong Kong 22
PL - Polonia 22
BE - Belgio 21
CO - Colombia 18
TR - Turchia 18
ZA - Sudafrica 16
ID - Indonesia 14
PE - Perù 14
JP - Giappone 13
PK - Pakistan 12
CH - Svizzera 11
PY - Paraguay 10
AT - Austria 9
IE - Irlanda 9
MD - Moldavia 9
CL - Cile 8
EG - Egitto 8
UZ - Uzbekistan 8
IL - Israele 7
UY - Uruguay 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
KE - Kenya 6
IR - Iran 5
RO - Romania 5
AL - Albania 4
BY - Bielorussia 4
CR - Costa Rica 4
HU - Ungheria 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
SM - San Marino 4
DK - Danimarca 3
DZ - Algeria 3
GE - Georgia 3
JO - Giordania 3
LT - Lituania 3
TW - Taiwan 3
BG - Bulgaria 2
BO - Bolivia 2
CG - Congo 2
CU - Cuba 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GR - Grecia 2
KG - Kirghizistan 2
LV - Lettonia 2
MU - Mauritius 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BZ - Belize 1
DO - Repubblica Dominicana 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
Totale 183.441
Salva come PNG Salva come JPEG
Città #
Cagliari 162.367
Uta 3.055
Chandler 764
Singapore 684
Ashburn 642
Woodbridge 634
Fairfield 625
Jacksonville 597
Boardman 566
Ann Arbor 491
Dallas 450
Houston 406
Nyköping 406
Wilmington 327
Munich 257
Seattle 257
Beijing 255
Helsinki 251
New York 224
Cambridge 214
Hefei 208
Boston 181
Los Angeles 168
Nanjing 161
Dearborn 125
Santa Clara 124
Seoul 112
Milan 103
Buffalo 90
Rome 80
Shanghai 80
Redwood City 68
Shenyang 61
Nanchang 59
Toronto 57
Tianjin 52
Chicago 51
Ho Chi Minh City 50
Hebei 49
Verona 46
Changsha 43
São Paulo 41
The Dalles 38
San Diego 35
Jiaxing 33
Guangzhou 31
Orange 30
Atlanta 29
Hanoi 28
Zhengzhou 27
Casablanca 26
Jinan 26
London 26
Washington 26
Norwalk 23
Hong Kong 21
Ningbo 21
Chennai 20
Council Bluffs 19
Florence 19
Redondo Beach 19
Brussels 17
Brooklyn 16
Elk Grove Village 16
Bologna 15
Rio de Janeiro 15
Sassari 15
Warsaw 15
Auburn Hills 14
Genoa 14
Hangzhou 14
Johannesburg 13
Mountain View 13
Quito 12
Saint Petersburg 12
Salt Lake City 12
San Jose 12
Tokyo 12
Caserta 11
Jyväskylä 11
Palermo 11
Phoenix 11
Pune 11
Turin 11
Turku 11
Catania 10
Cedar Knolls 10
Nuremberg 10
Sìnnai 10
Tampa 10
Trezzano sul Naviglio 10
Curitiba 9
Düsseldorf 9
Naples 9
San Francisco 9
Sterling 9
Taizhou 9
Bari 8
Berlin 8
Campinas 8
Totale 176.430
Salva come PNG Salva come JPEG
Nome #
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.029
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifabutina, rifampicina e amikacina nei confronti di Mycobacterium avium 4.581
Limonoids from Melia azedarach fruits as inhibitors of flaviviruses and mycobacterium tubercolosis 4.453
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.353
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases 3.468
Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells 3.037
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 2.724
Discovery of in vitro antitubercular agents through in silico ligand-based approaches 2.350
Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1 2.297
Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B 2.237
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action. 2.223
Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection 2.183
Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach 2.171
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.137
HPLC-DAD-MS analysis and antiviral activity of different extracts and isolated costituents from Bituminaria bituminosa 2.130
Imidazole and 1,2,4-triazole-based derivatives gifted with antitubercular activity: Cytotoxicity and computational assessment 2.076
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis 2.075
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.073
Improving the physical chemical properties of a very promising class of pyrrole antimycobacterial agents 2.021
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 1.975
Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives 1.967
null 1.953
null 1.949
In vivo potent BM635 analogue with improved drug-like properties 1.947
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis and microbiological evaluation 1.930
Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation 1.915
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.899
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug 1.885
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones 1.884
null 1.829
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings 1.799
Nuove strategie per lo sviluppo di farmaci antitubercolari: caratterizzazione di target alternativi e di fattori di virulenza in Mycobacterium tuberculosis 1.773
null 1.749
Design, synthesis and antimycobacterial activity of benzoxazinone derivatives and open-ring analogues: Preliminary data and computational analysis 1.747
Sherris. Microbiologia medica 1.737
Individuazione di nuovi target in MDR e XDR Mycobacterium tuberculosis mediante 1,5-difenil- e 1,5-diaril-2-etil-pirroli per lo sviluppo di nuovi agenti antitubercolari 1.667
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.637
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.635
Attività fungicida di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Candida spp. 1.612
Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis 1.577
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.561
Novel N-aryl- and N-heteryl-phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.530
Phenazine-1-carboxilyc acid derivatives suppressing the RNA polymerase as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.519
Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis 1.484
Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin 1.456
Effetto di Inibitori delle COX-1 e COX-2 sullo sviluppo del biofilm di Candida albicans: studio della associazione di FANS e derivati azolici per la profilassi delle infezioni fungine contratte in ambiente ospedaliero 1.449
Synergistic interaction in vitro between rifabutin and newly synthesized S-alkylisothiosemicarbazones derivatives against mycobacterium avium 1.438
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.435
dentification of a new Chemical Class of Potent Antimycobacterial Compounds 1.417
BM 579: a novel pyrrole derivative with improved antimycobacterial activity 1.403
Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis 1.373
Design, synthesis and microbiological characterization of 1,5-diphenyl and 1,5-diaryl-2-ethylpyrrole derivatives as new potential agents of infections sustained by MDR and XDR Mycobacterium tuberculosis. 1.345
Nuovo sistema di fermentazione in semi-solido per la produzione di enzimi cellulosolitici 1.324
Infezioni nosocomiali da Pseudomonas maltophilia in un reparto di terapia intensiva per neonat 1.261
Sul trattamento microbiologico delle acque di vegetazione 1.256
Synergistic interactions in vitro between Rifabutin and newly synthesized s-alkylthiosemicarbazone derivatives against M. avium 1.243
Saggi e dosaggi microbiologici della Farmacopea 1.211
Effetto di FANS sulla formazione di biofilm di Candida albicans e potenziamento della attività di farmaci antifungini 1.211
Studio di un metodo rapido mediante riduzione di XTT per la determinazione della resistenza in Mycobacterium tuberculosis 1.188
BM212 and its derivatives: lead optimization of a new class of antimycobacterial agents. 1.162
Pyrrole derivatives of BM212 as novel antimycobacterial agents Design, synthesis, biological evaluation and study of their mode of action 1.150
null 1.144
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.090
Antimycobacterial Activiy of New 1,4-Benzoxazine-2-one derivatives and its 2-(arylamino)-4-oxobut-2-enoate, ring-open analogues 1.090
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents.Design, synthesis, biological evaluation and study of their mode of action. 1.077
null 1.070
Design and synthesis of 1,5-diaryl-2-ethyl pyrrole derivatives and their evaluation as antimycobacterial agents 1.057
Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones 1.017
Derivatives of BM 212: synthesis and biological evaluation of new derivatives with improved antimycobacterial activity. 1.012
In vitro antiviral activity of liposomal Artemisia arborescens essential oil 1.000
New pyrrole derivatives of BM 212: lead compound optimization strategy, Tuberculosis drug development. Targets, technologies and trials. 978
L’OLIO ESSENZIALE DI ARTEMISIA ARBORESCENS INATTIVA HSV1 E HSV2 E INIBISCE LA DIFFUSIONE LATERALE DI CELLULE VERO 971
Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones 945
null 935
PHISICAL STABILITY OF ARTEMISIA ARBORESCENS L. ESSENTIAL OIL LOADED SLN AND IN VITRO ANTIVIRAL ACTIVITY 879
Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB 865
Influenza dell'inclusione liposomiale sull'attività in vitro di miconazolo e ketoconazolo 827
null 826
null 818
Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici 803
Effetti dei liposomi sull'attività in vitro di alcuni antifungini 774
L’olio essenziale di Artemisia arborescens inattiva HSV-1 e HSV-2 e inibisce la diffusione laterale in cellule Vero 766
null 764
null 736
Studio dell’attività di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Aspergillus spp 735
Aspetti Microbiologici della Produzione Farmaceutica 715
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium 692
Strategie alternative per la profilassi delle infezioni sostenute da Candida albicans contratte in ambiente ospedaliero mediante isotiosemicarbazoni ciclici 676
Isothiosemicarbazones as alternative approach to the therapy of infections sustained by Candida albicans 667
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico. 638
Degradazione biologica degli aghi di pino (Pinus Silvester) 638
Liposomes as carrier for Artemisia arborescens essential oil: preparation, characterisation and antiviral activity 627
Attività intramacrofagica di nuovi agenti antitubercolari per il trattamento delle infezioni sostenute da ceppi MDR mediante inibizione selettiva della RNA polimerasi. 626
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis 623
 and  opiate receptors mediate specific behavioral syndromes from the Substantia Nigra. 610
null 605
PHYSICAL STABILITY OF ARTEMISIA ARBORESCENS ESSENTIAL OIL LOADED SLN AND IN VITRO ANTIVIRAL ACTIVITY 566
Aspetti microbiologici della produzione farmaceutica 564
Saggi e dosaggi microbiologici della Farmacopea 548
Stafilococchi 538
Totale 151.612
Salva come PNG Salva come JPEG
Categoria #
all - tutte 235.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 235.263
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117.731 0 0 0 0 0 5.002 4.000 2.524 1.105 2.050 1.688 1.362
2021/20228.886 1.427 908 478 567 715 541 389 529 756 769 902 905
2022/202312.524 1.314 1.647 1.447 886 818 1.183 645 1.462 742 620 954 806
2023/202416.879 940 523 1.037 1.211 1.661 3.247 2.625 943 684 1.201 1.491 1.316
2024/202534.953 7.713 11.595 4.674 2.829 1.715 1.663 2.824 277 451 317 443 452
2025/20264.460 490 699 1.088 1.127 500 556 0 0 0 0 0 0
Totale 183.693